Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aromatase, encoded by the CYP19A1 gene, is a key enzyme in estrogen biosynthesis, converting androgens like testosterone and androstenedione into estrogens such as estradiol and estrone. It plays a critical role in sexual development, reproductive function, and is a therapeutic target in hormone-dependent cancers, particularly breast cancer. Aromatase inhibitors are used to block estrogen synthesis, but their use can have systemic effects, including cardiovascular risks.
Blocking estrogen synthesis by inhibiting aromatase enzyme activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aromatase.